Manjunath Gangadharan Sells 1,802 Shares of Adtalem Global Education (NYSE:CVSA) Stock

Adtalem Global Education Inc. (NYSE:CVSA) CAO Manjunath Gangadharan sold 1,802 shares of the stock in a transaction that occurred on Thursday, August 27th. The shares were sold at an average price of $137.18, for a total transaction of $247,198.36. Following the transaction, the chief accounting officer owned 5,083 shares in the company, valued at approximately $697,285.94. This represents a 26.17% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Stock Down 4.2%

Shares of CVSA stock opened at $134.71 on Friday. The stock has a market capitalization of $4.59 billion, a price-to-earnings ratio of 19.13, a price-to-earnings-growth ratio of 1.00 and a beta of 0.62. Adtalem Global Education Inc. has a 52-week low of $86.97 and a 52-week high of $156.26. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.45. The company’s 50 day simple moving average is $127.39.

Adtalem Global Education (NYSE:CVSA) last posted its earnings results on Thursday, August 6th. The company reported $2.09 earnings per share for the quarter, topping analysts’ consensus estimates of $1.90 by $0.19. The company had revenue of $501.38 million during the quarter. Adtalem Global Education had a return on equity of 20.88% and a net margin of 12.87%.Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS. Analysts anticipate that Adtalem Global Education Inc. will post 9 EPS for the current fiscal year.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Adtalem Global Education stock. Kendall Capital Management acquired a new position in shares of Adtalem Global Education Inc. (NYSE:CVSA) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 11,622 shares of the company’s stock, valued at approximately $1,449,000. 98.84% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on CVSA shares. Barrington Research reaffirmed an “outperform” rating and set a $170.00 price objective on shares of Adtalem Global Education in a research report on Monday, June 8th. Truist Financial boosted their target price on shares of Adtalem Global Education from $130.00 to $140.00 and gave the stock a “buy” rating in a report on Monday, May 11th. Wall Street Zen upgraded shares of Adtalem Global Education from a “hold” rating to a “buy” rating in a report on Saturday, August 8th. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Adtalem Global Education in a research report on Wednesday, August 19th. Two investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $155.00.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.